Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Dietrich D, Jung M, Puetzer S, Leisse A, Holmes EE, Meller S, Uhl B, Schatz P, Ivascu C, Kristiansen G.

PLoS One. 2013 Dec 27;8(12):e84225. doi: 10.1371/journal.pone.0084225. eCollection 2013.

PMID:
24386354
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.

Demokan S, Chuang AY, Pattani KM, Sidransky D, Koch W, Califano JA.

Oncol Rep. 2014 Feb;31(2):1014-20. doi: 10.3892/or.2013.2927. Epub 2013 Dec 16.

PMID:
24337411
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.

Connolly D, Hoang HG, Adler E, Tazearslan C, Simmons N, Bernard VV, Castaldi M, Oktay MH, Montagna C.

Biol Chem. 2014 Feb;395(2):157-67. doi: 10.1515/hsz-2013-0247.

PMID:
24127542
[PubMed - indexed for MEDLINE]
4.

SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.

Golan M, Mabjeesh NJ.

Cell Cycle. 2013 Jul 15;12(14):2297-308. doi: 10.4161/cc.25379.

PMID:
24067372
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.

Gyparaki MT, Basdra EK, Papavassiliou AG.

J Mol Med (Berl). 2013 Nov;91(11):1249-56. doi: 10.1007/s00109-013-1088-z. Epub 2013 Sep 21. Review.

PMID:
24057814
[PubMed - indexed for MEDLINE]
6.

Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis.

Estey MP, Di Ciano-Oliveira C, Froese CD, Fung KY, Steels JD, Litchfield DW, Trimble WS.

J Biol Chem. 2013 Oct 18;288(42):30075-86. doi: 10.1074/jbc.M113.474932. Epub 2013 Aug 29.

PMID:
23990466
[PubMed - indexed for MEDLINE]
7.

Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.

Wasserkort R, Kalmar A, Valcz G, Spisak S, Krispin M, Toth K, Tulassay Z, Sledziewski AZ, Molnar B.

BMC Cancer. 2013 Aug 30;13:398. doi: 10.1186/1471-2407-13-398.

PMID:
23988185
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study.

Liu Y, Tham CK, Ong SY, Ho KS, Lim JF, Chew MH, Lim CK, Zhao Y, Tang CL, Eu KW.

Biomarkers. 2013 Aug;18(5):399-405. doi: 10.3109/1354750X.2013.798745.

PMID:
23862763
[PubMed - indexed for MEDLINE]
9.

Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.

Ladabaum U, Allen J, Wandell M, Ramsey S.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1567-76. doi: 10.1158/1055-9965.EPI-13-0204. Epub 2013 Jun 24.

PMID:
23796793
[PubMed - indexed for MEDLINE]
Free Article
10.

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V.

Cancer Prev Res (Phila). 2013 Jul;6(7):656-65. doi: 10.1158/1940-6207.CAPR-12-0501. Epub 2013 May 21.

PMID:
23694962
[PubMed - indexed for MEDLINE]
11.

DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.

Fukushige S, Horii A.

Tohoku J Exp Med. 2013;229(3):173-85. Review.

PMID:
23419314
[PubMed - indexed for MEDLINE]
Free Article
12.

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.

Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, Snover D, Day RW, Ransohoff DF; PRESEPT Clinical Study Steering Committee, Investigators and Study Team.

Gut. 2014 Feb;63(2):317-25. doi: 10.1136/gutjnl-2012-304149. Epub 2013 Feb 13.

PMID:
23408352
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.

Tóth K, Sipos F, Kalmár A, Patai AV, Wichmann B, Stoehr R, Golcher H, Schellerer V, Tulassay Z, Molnár B.

PLoS One. 2012;7(9):e46000. doi: 10.1371/journal.pone.0046000. Epub 2012 Sep 25.

PMID:
23049919
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Neonatal vocal cord paralysis-an early presentation of hereditary neuralgic amyotrophy due to a mutation in the SEPT9 gene.

Leshinsky-Silver E, Ginzberg M, Dabby R, Sadeh M, Lev D, Lerman-Sagie T.

Eur J Paediatr Neurol. 2013 Jan;17(1):64-7. doi: 10.1016/j.ejpn.2012.08.006. Epub 2012 Sep 13.

PMID:
22981636
[PubMed - indexed for MEDLINE]
15.

Sensitive and selective amplification of methylated DNA sequences using helper-dependent chain reaction in combination with a methylation-dependent restriction enzymes.

Rand KN, Young GP, Ho T, Molloy PL.

Nucleic Acids Res. 2013 Jan 7;41(1):e15. doi: 10.1093/nar/gks831. Epub 2012 Sep 10.

PMID:
22965136
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.

Sellin ME, Stenmark S, Gullberg M.

Mol Biol Cell. 2012 Nov;23(21):4242-55. doi: 10.1091/mbc.E12-06-0486. Epub 2012 Sep 5.

PMID:
22956766
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.

Cerveira N, Lisboa S, Correia C, Bizarro S, Santos J, Torres L, Vieira J, Barros-Silva JD, Pereira D, Moreira C, Meyer C, Oliva T, Moreira I, Martins Â, Viterbo L, Costa V, Marschalek R, Pinto A, Mariz JM, Teixeira MR.

Mol Oncol. 2012 Oct;6(5):553-64. doi: 10.1016/j.molonc.2012.06.004. Epub 2012 Jul 14.

PMID:
22846743
[PubMed - indexed for MEDLINE]
Free Article
18.

DNA methylation biomarkers in cancer: progress towards clinical implementation.

Mikeska T, Bock C, Do H, Dobrovic A.

Expert Rev Mol Diagn. 2012 Jun;12(5):473-87. doi: 10.1586/erm.12.45. Review.

PMID:
22702364
[PubMed - indexed for MEDLINE]
19.

Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.

Li H, Du Y, Zhang D, Wang LN, Yang C, Liu B, Wang WJ, Shi L, Hong WG, Zhang L, Yang YX.

Oncol Rep. 2012 Jul;28(1):99-104. doi: 10.3892/or.2012.1779. Epub 2012 Apr 23.

PMID:
22552777
[PubMed - indexed for MEDLINE]
20.

Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Chacko AD, McDade SS, Chanduloy S, Church SW, Kennedy R, Price J, Hall PA, Russell SE.

Cell Oncol (Dordr). 2012 Apr;35(2):85-93. doi: 10.1007/s13402-011-0066-0. Epub 2012 Jan 26.

PMID:
22278362
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk